Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the immunogenicity and safety of GSK's HZ/su herpes zoster vaccine in adults with prior herpes zoster infection; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• HZ/su (GSK1437173A) (HZ/su vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED | Results posted: 2017-03-07